Charles River Laboratories (CRL): Officer bought, ~$4.4K

~$4.4K
Approx. value · 25 sh @ $174.54: 27K
Holds after · shares reported

Traded: Mar 3, 2026
Filed: Mar 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Aug 22, 2025InsiderOfficer sold ~$65K of CRL shares in the open market
Jan 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 8, 2026, the Board of Directors (the “Board”) of Charles River Laboratories International, Inc. (the “Company”) announced a leadership transition plan.”
Jan 13, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
Jan 20, 2026Federal contract · $1.9M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $1.92M obligated to date
Feb 10, 20265% stakeWellington Management Group LLP reported a passive stake (13G) of 3.6%
Feb 12, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 5.5%
Feb 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 18, 2026, the Company announced the appointment of Glenn Coleman as its Corporate Executive Vice President and Chief Financial Officer. Mr. Coleman will join the company with a tentative start date of April 6, 2026.”
Feb 18, 2026Company filing · Form 8-K · ResultsReported its results
Feb 25, 2026Federal contract · $936K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $936K obligated to date
Mar 3, 2026 · this disclosureInsider · First insider buy since Feb 2025Officer purchased ~$4.4K of CRL shares in the open market

What came next

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Charles River Laboratories

For Charles River Laboratories, OQRO holds 19 insider filings (SEC Form 4 or Form 144), 11 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.

Other recent filings by Joseph W Laplume, EVP, Corp Strategy & Develop

The full history of Joseph W Laplume, EVP, Corp Strategy & Develop is on the profile page.

Other disclosures at Charles River Laboratories

Everything OQRO holds on this company is on its CRL page.

Charles River Laboratories (CRL)Officer bought ~$4.4K